P3 Health Partners Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2025: USD 118.03 M

P3 Health Partners Inc. Net Cash Used Provided By Financing Activities is USD 118.03 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 20.89% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • P3 Health Partners Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 97.63 M, a 265.87% change year over year.
  • P3 Health Partners Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 26.68 M.
  • P3 Health Partners Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 34.74 M.
Key Data
Date Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid Common Stock Issued